Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia

by Steffie K Naber, Majid A Almadi, Gordon Guyatt, Feng Xie, Iris Lansdorp-Vogelaar
Published 2021-01-01

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.

by Steffie K Naber, Suzette M Matthijsse, Kirsten Rozemeijer, Corine Penning, Inge M C M de Kok, Marjolein van Ballegooijen
Published 2016-01-01

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries.

by Steffie K Naber, Amy B Knudsen, Ann G Zauber, Carolyn M Rutter, Sara E Fischer, Chester J Pabiniak, Brittany Soto, Karen M Kuntz, Iris Lansdorp-Vogelaar
Published 2019-01-01

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.

by Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Published 2018-01-01